Liver abscess in advanced hepatocellular carcinoma after atezolizumab plus bevacizumab treatment: A case report
Authors:
- Keisuke UchidaKUKeisuke Uchida
- Yoshinori OzonoYOYoshinori Ozono
- Naomi UchiyamaNUNaomi Uchiyama
- Kenichi NakamuraKNKenichi Nakamura
- Yuri KomakiYKYuri Komaki
- Hisayoshi IwakiriHIHisayoshi Iwakiri
- Satoru HasuikeSHSatoru Hasuike
- Kenji NagataKNKenji Nagata
- Yuichiro SatoYSYuichiro Sato
- Hiroshi KawakamiHKHiroshi Kawakami
Open Access
- 2 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (35) , e30486
Abstract
Rationale: Hepatocellular carcinoma (HCC) is the sixth most common type of cancer globally. Since 2020, combination treatment with atezolizumab and bevacizumab were approved in patients with unresectable HCC in Japan, and atezolizumab plus bevacizumab is the first-line treatment for unresectable HCC. Patient concerns: A 73-year-old Japanese man diagnosed with a large HCC was treated with atezolizumab plus bevacizumab. After 2 cycles, he had fever and fatigue and was admitted to the hospital. Diagnosis: Abdominal contrast-enhanced computed tomography revealed tumor necrosis in HCC with gas formation in the necrotic area. Laboratory examination revealed a white blood cell (WBC) count of 16,340/μL and C-reactive protein (CRP) level of 33.0 mg/dL. Based on the above findings, he was diagnosed with a liver abscess. Interventions: Percutaneous transhepatic liver abscess drainage and broad-spectrum antibiotics treatment were performed. Outcomes: Despite liver abscess drainage, persistent fever and no improvement in the WBC count or CRP level was observed. The patient’s respiratory condition and renal function gradually worsened; The patient’s general condition did not improve despite the ventilator support and continuous hemodiafiltration, and he died on day 37. Lessons: We report the first case of liver abscess after atezolizumab plus bevacizumab treatment for unresectable HCC.Keywords
This publication has 22 references indexed in Scilit:
- Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literatureInternational Journal of Infectious Diseases, 2016
- Liver Abscess in Advanced Hepatocellular Carcinoma after Sorafenib TreatmentThe Korean Journal of Gastroenterology, 2014
- Pyogenic liver abscessFrontline Gastroenterology, 2013
- A rare human infection of Raoultella ornithinolytica in a diabetic foot lesionAnnals of Saudi Medicine, 2011
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialThe Lancet Oncology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Sepsis From Liver Abscesses in Metastatic Colorectal Carcinoma After ChemoimmunotherapyJournal of Clinical Oncology, 2008
- Liver abscess complicating transcatheter arterial embolizationEuropean Journal of Gastroenterology & Hepatology, 2004
- Treatment of Focal Liver Tumors with Percutaneous Radio-frequency Ablation: Complications Encountered in a Multicenter StudyRadiology, 2003
- Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb. nov.International Journal of Systematic and Evolutionary Microbiology, 2001